AbClon Inc.
AbClon Inc. has a source-backed asset record in this dataset as of 2026-11-01.
- Country / operating region
- South Korea
- Ticker
- 174900.KQ
- Headquarters
- 查無
- Founded
- 查無
- Business
- Biopharmaceutical research and development
- Website
- www.abclon.com
Pipeline / products
| Asset | Registered / announced phase | Trial | Status | Sponsor | Record date |
|---|---|---|---|---|---|
| AT101 (nespecabtagene autoleucel) | Phase 2 interim results (May 2025 milestone) | — | 查無 | 查無 | 2025-05 |
Licensing deals
查無
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無